⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6637501 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL5562938 | 0.96 | — | — | |
| Formic Acid SCHEMBL31538578 | 0.89 | — | — | |
| SCHEMBL3844855 | 0.82 | — | — | |
| SCHEMBL2298640 | 0.78 | — | — | |
| Trifluoroacetic Acid SCHEMBL4606826 | 0.76 | NOS1 (0.37) | — | |
| Hydrochloric Acid SCHEMBL5183654 | 0.75 | — | — | |
| SCHEMBL7058496 | 0.75 | — | — | |
| SCHEMBL5992994 | 0.75 | — | — | |
| SCHEMBL10928502 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 530 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630600-B2 | GLP-1 and glucagon dual agonist peptides with improved biological stability | MEDIMMUNE LIMITED (GB) | 2026-05-19 | — | — | US | claimed |
| EP-4476248-A1 | GLP-1 AND GLUCAGON DUAL AGONIST PEPTIDES WITH IMPROVED BIOLOGICAL STABILITY | MedImmune Limited (GB) | 2024-12-18 | — | — | EP | claimed |
| US-20230391845-A1 | GLP-1, GIP AND GLUCAGON RECEPTOR TRIPLE AGONISTS | NOVO NORDISK A/S (DK) | 2023-12-07 | — | — | US | claimed |
| US-20230357348-A1 | GLP-1 AND GLUCAGON DUAL AGONIST PEPTIDES WITH IMPROVED BIOLOGICAL STABILITY | MEDIMMUNE LIMITED (GB) | 2023-11-09 | — | — | US | claimed |
| EP-4236991-A1 | GLP-1, GIP AND GLUCAGON RECEPTOR TRIPLE AGONISTS | Novo Nordisk A/S (DK) | 2023-09-06 | — | — | EP | claimed |
| WO-2023148366-A1 | GLP-1 AND GLUCAGON DUAL AGONIST PEPTIDES WITH IMPROVED BIOLOGICAL STABILITY | MEDIMMUNE LIMITED (GB) | 2023-08-10 | — | — | WO | claimed |
| CN-116457002-A | GLP-1, GIP and glucagon receptor triple agonists | 诺和诺德股份有限公司 | 2023-07-18 | — | — | CN | claimed |
| WO-2022090447-A1 | GLP-1, GIP AND GLUCAGON RECEPTOR TRIPLE AGONISTS | NOVO NORDISK A/S (DK) | 2022-05-05 | — | — | WO | claimed |
| EP-1915149-B1 | NOVEL TRIAZOLE DERIVATIVES AS GHRELIN ANALOGUE LIGANDS OF GROWTH HORMONE SECRETAGOGUE RECEPTORS | AETERNA ZENTARIS GMBH (DE) | 2018-10-10 | — | — | EP | claimed |
| CN-103260404-B | Protected antimicrobial compounds for high temperature applications | DOW GLOBAL TECHNOLOGIES INC | 2015-04-01 | — | — | CN | claimed |
| WO-1997022620-A1 | OLIGOPEPTIDE COMPOUNDS CONTAINING D-2-ALKYLTRYPTOPHAN CAPABLE OF PROMOTING THE RELEASE OF GROWTH HORMONE | DEGHENGHI ROMANO (CH) | 1997-06-26 | — | — | WO | claimed |
| EP-0674652-A1 | DOLOSTATIN ANALOG | BASF AKTIENGESELLSCHAFT (DE) | 1995-10-04 | — | — | EP | claimed |
| EP-0642530-A1 | DERIVATIVES OF DOLASTATIN | BASF Aktiengesellschaft (DE) | 1995-03-15 | — | — | EP | claimed |
| WO-1994013695-A1 | DOLOSTATIN ANALOG | BASF AKTIENGESELLSCHAFT (DE) | 1994-06-23 | — | — | WO | claimed |
| WO-1993023424-A1 | DERIVATIVES OF DOLASTATIN | BASF AKTIENGESELLSCHAFT (DE) | 1993-11-25 | — | — | WO | claimed |
| EP-0160508-B1 | PHENOL DERIVATIVES | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1989-05-31 | — | — | EP | claimed |
| US-4760061-A | Antioestrogenic agent | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1988-07-26 | — | — | US | claimed |
| EP-0160508-A2 | Phenol derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1985-11-06 | — | — | EP | claimed |
| US-4503040-A | 6-(Aminoacyloxymethyl)penicillanic acid 1,1-dioxides as beta-lactamase inhibitors | PFIZER INC. (US) | 1985-03-05 | — | — | US | claimed |
| US-4232008-A | THYMIC FUNCTION AND IMMUNITY | ORTHO PHARMACEUTICAL CORPORATION (US) | 1980-11-04 | — | — | US | claimed |